Allogeneic dental pulp mesenchymal stem cell therapy - Beijing SH Bio-Tech Corporation/Utooth Biological Technology
Latest Information Update: 22 Apr 2020
Price :
$50 *
At a glance
- Originator Beijing SH Bio-Tech Corporation; Utooth Biological Technology Co
- Class Antivirals; Mesenchymal stem cell therapies; Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I/II COVID-19 pneumonia
Most Recent Events
- 06 Apr 2020 Phase-I/II clinical trials in COVID-19 pneumonia in China (IV) (NCT04336254)